var data={"title":"Statins: Possible noncardiovascular benefits","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Statins: Possible noncardiovascular benefits</div><dl id=\"topicContributors\"><dt><span> </span>Author:</dt><dd><a href=\"https://www.uptodate.com/contents/statins-possible-noncardiovascular-benefits/contributors\" class=\"contributor contributor_credentials\">Robert S Rosenson, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/statins-possible-noncardiovascular-benefits/contributors\" class=\"contributor contributor_credentials\">Mason W Freeman, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/statins-possible-noncardiovascular-benefits/contributors\" class=\"contributor contributor_credentials\">Gordon M Saperia, MD, FACC</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/statins-possible-noncardiovascular-benefits/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Aug 24, 2017.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H1\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Lipid lowering, at least with statins, is beneficial in patients with dyslipidemias for both primary and secondary prevention of coronary heart disease. (See <a href=\"topic.htm?path=management-of-low-density-lipoprotein-cholesterol-ldl-c-in-secondary-prevention-of-cardiovascular-disease\" class=\"medical medical_review\">&quot;Management of low density lipoprotein cholesterol (LDL-C) in secondary prevention of cardiovascular disease&quot;</a>.)</p><p>In addition to cholesterol lowering and the primary and secondary prevention of cardiovascular disease, statin therapy may be associated with other benefits. Most of these other benefits have been found as associations in observational studies, rather than in randomized trials. As such, there is potential confounding and bias in that patients receiving better medical care, and those more adherent to medical therapy, may be more likely to be taking statins and also be at lower risk for certain noncardiovascular diseases.</p><p>Potential noncardiovascular benefits of statins are discussed here. Side effects and toxicities of statins are discussed separately. (See <a href=\"topic.htm?path=statins-actions-side-effects-and-administration\" class=\"medical medical_review\">&quot;Statins: Actions, side effects, and administration&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H2\"><span class=\"h1\">DEMENTIA</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Some observational studies have suggested that statins may decrease the risk of dementia and at least one small randomized trial has suggested that statins may slow the progression of dementia. (See <a href=\"topic.htm?path=treatment-of-dementia#H19\" class=\"medical medical_review\">&quot;Treatment of dementia&quot;, section on 'Risk factor control'</a> and <a href=\"topic.htm?path=prevention-of-dementia#H1682154743\" class=\"medical medical_review\">&quot;Prevention of dementia&quot;, section on 'Statins'</a>.)</p><p class=\"headingAnchor\" id=\"H3\"><span class=\"h1\">CANCER</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Some [<a href=\"https://www.uptodate.com/contents/statins-possible-noncardiovascular-benefits/abstract/1-4\" class=\"abstract_t\">1-4</a>], but not all [<a href=\"https://www.uptodate.com/contents/statins-possible-noncardiovascular-benefits/abstract/5-9\" class=\"abstract_t\">5-9</a>], observational studies have raised the possibility that use of statins may decrease overall risk of cancer and of specific cancers.</p><p>In contrast, meta-analyses of randomized trials have consistently shown no effect of statins on cancer incidence or cancer mortality [<a href=\"https://www.uptodate.com/contents/statins-possible-noncardiovascular-benefits/abstract/10-13\" class=\"abstract_t\">10-13</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>A meta-analysis of individual patient data from 27 randomized trials of statins involving 174,149 patients found no increased risk of cancer death after a median follow-up of 4.9 years (RR 0.98, 95% CI 0.92-1.05) [<a href=\"https://www.uptodate.com/contents/statins-possible-noncardiovascular-benefits/abstract/13\" class=\"abstract_t\">13</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>A second meta-analysis of 26 randomized trials of statins involving 86,936 patients, where the trials were required to have a mean follow-up of at least one year, also found no effect of statins on cancer incidence (odds ratio [OR] 1.02, CI 0.97-1.07) or cancer death (OR 1.01, CI 0.93-1.09) [<a href=\"https://www.uptodate.com/contents/statins-possible-noncardiovascular-benefits/abstract/11\" class=\"abstract_t\">11</a>]. This lack of effect on cancer was true across different cancers and for various statin subtypes (ie, hydrophilic, lipophilic, natural, synthetic).</p><p/><p>It is implausible that a large early reduction in risk for a common cancer, such as the 55 percent reduction seen in a large case-control study of lung cancer within six months of initiating statin therapy [<a href=\"https://www.uptodate.com/contents/statins-possible-noncardiovascular-benefits/abstract/14\" class=\"abstract_t\">14</a>], would have been missed in these meta-analyses. It is likely that most of the positive results seen in observational studies of statins and cancer are due to bias or confounding.</p><p>In summary, there is no convincing evidence that statins increase or decrease the risk of cancer.</p><p>Additionally, although observational studies have suggested better outcomes in patients with cancer who were taking statins prior to or after their cancer diagnosis [<a href=\"https://www.uptodate.com/contents/statins-possible-noncardiovascular-benefits/abstract/15-17\" class=\"abstract_t\">15-17</a>], similar concerns about residual confounding make these results unconvincing until confirmed in higher-quality trials [<a href=\"https://www.uptodate.com/contents/statins-possible-noncardiovascular-benefits/abstract/18\" class=\"abstract_t\">18</a>].</p><p class=\"headingAnchor\" id=\"H4\"><span class=\"h1\">RENAL FUNCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Post-hoc analyses of clinical trials have raised the possibility that statins may be of some benefit in preserving renal function, both in patients with moderate chronic renal insufficiency [<a href=\"https://www.uptodate.com/contents/statins-possible-noncardiovascular-benefits/abstract/19\" class=\"abstract_t\">19</a>] and in patients with normal renal function [<a href=\"https://www.uptodate.com/contents/statins-possible-noncardiovascular-benefits/abstract/20\" class=\"abstract_t\">20</a>]. (See <a href=\"topic.htm?path=secondary-factors-and-progression-of-chronic-kidney-disease#H11\" class=\"medical medical_review\">&quot;Secondary factors and progression of chronic kidney disease&quot;, section on 'Hyperlipidemia'</a> and <a href=\"topic.htm?path=statins-and-chronic-kidney-disease\" class=\"medical medical_review\">&quot;Statins and chronic kidney disease&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H5\"><span class=\"h1\">SEPSIS AND INFECTIONS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Animal models of sepsis suggested that statins may improve outcomes [<a href=\"https://www.uptodate.com/contents/statins-possible-noncardiovascular-benefits/abstract/21-25\" class=\"abstract_t\">21-25</a>], and initial observational studies in bacteremic patients suggested that prior statin therapy may decrease the rates of severe sepsis and mortality from sepsis [<a href=\"https://www.uptodate.com/contents/statins-possible-noncardiovascular-benefits/abstract/26-28\" class=\"abstract_t\">26-28</a>]. This issue has been addressed in a number of observational studies [<a href=\"https://www.uptodate.com/contents/statins-possible-noncardiovascular-benefits/abstract/29-35\" class=\"abstract_t\">29-35</a>], and a meta-analysis of observational studies found an association between statins and prevention of infection, but there was significant heterogeneity among studies as well as some evidence of publication bias [<a href=\"https://www.uptodate.com/contents/statins-possible-noncardiovascular-benefits/abstract/36\" class=\"abstract_t\">36</a>]. A 2012 meta-analysis of observational and experimental studies also suggested that being on statin therapy reduces mortality in patients with community-acquired pneumonia; however, the authors were concerned about residual confounding affecting the results [<a href=\"https://www.uptodate.com/contents/statins-possible-noncardiovascular-benefits/abstract/37\" class=\"abstract_t\">37</a>].</p><p>A 2011 meta-analysis of 11 randomized trials of statins (n = 30,947) found no effect of statin therapy on infections (relative risk [RR] 1.00, 95% CI 0.96-1.05) or infection related mortality (RR 0.97, CI 0.83-1.13) [<a href=\"https://www.uptodate.com/contents/statins-possible-noncardiovascular-benefits/abstract/38\" class=\"abstract_t\">38</a>]. In a subsequent report from the large JUPITER trial (n = 17,802), treatment with <a href=\"topic.htm?path=rosuvastatin-drug-information\" class=\"drug drug_general\">rosuvastatin</a> was associated with a reduction in the risk of incident pneumonia (hazard ratio [HR] 0.83, CI 0.69-1.00), however, treatment did not appear to reduce the risk of sepsis (HR 1.21, CI 0.82-1.78), all infections (HR 0.98, CI 0.94-1.03), or severe infections (HR 0.90, CI 0.79-1.03) [<a href=\"https://www.uptodate.com/contents/statins-possible-noncardiovascular-benefits/abstract/39\" class=\"abstract_t\">39</a>]. As multiple infection outcomes were studied, the apparent benefit in pneumonia may have been due to chance.</p><p>Given these results, it is unlikely that prior statin therapy has an important effect on the risk or outcomes of infections. The utility of initiating statins in ill patients to prevent or ameliorate sepsis is discussed separately. (See <a href=\"topic.htm?path=investigational-and-ineffective-therapies-for-sepsis#H21\" class=\"medical medical_review\">&quot;Investigational and ineffective therapies for sepsis&quot;, section on 'Statins'</a>.)</p><p class=\"headingAnchor\" id=\"H6\"><span class=\"h1\">VENOUS THROMBOEMBOLISM</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>There is some evidence that statin therapy may decrease the risk of venous thromboembolic disease. (See <a href=\"topic.htm?path=prevention-of-venous-thromboembolic-disease-in-acutely-ill-hospitalized-medical-adults#H2349552413\" class=\"medical medical_review\">&quot;Prevention of venous thromboembolic disease in acutely ill hospitalized medical adults&quot;, section on 'Effect of statin or aspirin on risk'</a>.)</p><p class=\"headingAnchor\" id=\"H338909734\"><span class=\"h1\">MULTIPLE SCLEROSIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>There have been conflicting results from randomized trials looking at whether statins could be beneficial in patients with multiple sclerosis. (See <a href=\"topic.htm?path=treatment-of-progressive-multiple-sclerosis-in-adults#H2086805171\" class=\"medical medical_review\">&quot;Treatment of progressive multiple sclerosis in adults&quot;, section on 'Simvastatin'</a>.)</p><p class=\"headingAnchor\" id=\"H7\"><span class=\"h1\">OTHER</span></p><p class=\"headingAnchor\" id=\"H8\"><span class=\"h2\">Bone metabolism</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>There is some evidence that statins may increase bone formation, volume, and density, and reduce the risk of osteoporotic fractures, particularly in older patients; however, there have been conflicting results. (See <a href=\"topic.htm?path=drugs-that-affect-bone-metabolism\" class=\"medical medical_review\">&quot;Drugs that affect bone metabolism&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H9\"><span class=\"h2\">Hypertension</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>There is some evidence that statins may lower blood pressure [<a href=\"https://www.uptodate.com/contents/statins-possible-noncardiovascular-benefits/abstract/40,41\" class=\"abstract_t\">40,41</a>]. (See <a href=\"topic.htm?path=antihypertensive-drugs-and-lipids\" class=\"medical medical_review\">&quot;Antihypertensive drugs and lipids&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H10\"><span class=\"h2\">Heart failure</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>There is evidence that statins may improve outcomes in patients with heart failure; this effect may be independent of the effect of statins on myocardial infarction. (See <a href=\"topic.htm?path=statin-therapy-in-patients-with-heart-failure\" class=\"medical medical_review\">&quot;Statin therapy in patients with heart failure&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H45574360\"><span class=\"h2\">COPD outcomes</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Although observational studies had suggested that statin therapy might reduce exacerbations of chronic obstructive pulmonary disease (COPD), a randomized trial failed to confirm this benefit. (See <a href=\"topic.htm?path=management-of-exacerbations-of-chronic-obstructive-pulmonary-disease#H20\" class=\"medical medical_review\">&quot;Management of exacerbations of chronic obstructive pulmonary disease&quot;, section on 'Prevention'</a>.)</p><p class=\"headingAnchor\" id=\"H11\"><span class=\"h2\">Pancreatic and biliary effects</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Statins may decrease the risk of requiring cholecystectomy for gallstones (see <a href=\"topic.htm?path=epidemiology-of-and-risk-factors-for-gallstones#H20\" class=\"medical medical_review\">&quot;Epidemiology of and risk factors for gallstones&quot;, section on 'Statins'</a>). Perhaps because of an effect on biliary tract stones, statins appear to reduce the risk of pancreatitis. In a meta-analysis of 16 randomized trials comparing statin therapy with placebo or control therapy in patients with normal or mildly elevated triglyceride levels (N = 113,800), statins reduced the risk of pancreatitis (relative risk 0.77, 95% CI 0.62-0.97) [<a href=\"https://www.uptodate.com/contents/statins-possible-noncardiovascular-benefits/abstract/42\" class=\"abstract_t\">42</a>]. This effect is likely not clinically important since in these trials, which had a mean follow-up of 4.1 years, only 0.27 percent of patients developed pancreatitis; 1175 such patients would need to receive statin therapy for five years to prevent one case of pancreatitis.</p><p class=\"headingAnchor\" id=\"H87225680\"><span class=\"h2\">Erectile dysfunction</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Some studies and models have suggested that statins could improve erectile dysfunction [<a href=\"https://www.uptodate.com/contents/statins-possible-noncardiovascular-benefits/abstract/43-45\" class=\"abstract_t\">43-45</a>]. In a six-month randomized trial in 173 men with erectile dysfunction, treatment with <a href=\"topic.htm?path=simvastatin-drug-information\" class=\"drug drug_general\">simvastatin</a> produced a statistically-nonsignificant improvement on an erectile dysfunction index (1.28 versus 0.07 points, p = 0.27); this increase was also clinically insignificant based on the researchers&rsquo; a priori assumption that a three-point difference in the score would be clinically meaningful [<a href=\"https://www.uptodate.com/contents/statins-possible-noncardiovascular-benefits/abstract/46\" class=\"abstract_t\">46</a>]. Two randomized trials in men with erectile dysfunction initially unresponsive to <a href=\"topic.htm?path=sildenafil-drug-information\" class=\"drug drug_general\">sildenafil</a> suggested that <a href=\"topic.htm?path=atorvastatin-drug-information\" class=\"drug drug_general\">atorvastatin</a> could improve erectile responsiveness to sildenafil [<a href=\"https://www.uptodate.com/contents/statins-possible-noncardiovascular-benefits/abstract/47,48\" class=\"abstract_t\">47,48</a>].</p><p>Additional research is needed to determine whether statin therapy can have a clinically-important effect on erectile dysfunction.</p><p class=\"headingAnchor\" id=\"H12\"><span class=\"h1\">SUMMARY</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Lipid lowering, at least with statins, is beneficial in patients with dyslipidemias for both primary and secondary prevention of coronary heart disease. (See <a href=\"topic.htm?path=management-of-low-density-lipoprotein-cholesterol-ldl-c-in-secondary-prevention-of-cardiovascular-disease\" class=\"medical medical_review\">&quot;Management of low density lipoprotein cholesterol (LDL-C) in secondary prevention of cardiovascular disease&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>A number of noncardiovascular benefits to statin therapy have been suggested. Many of these reflect associations in observational studies and may be due to confounding <span class=\"nowrap\">and/or</span> bias. (See <a href=\"#H1\" class=\"local\">'Introduction'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Statins do not appear to increase or decrease the risk of cancer. (See <a href=\"#H3\" class=\"local\">'Cancer'</a> above.)</p></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li><a href=\"https://www.uptodate.com/contents/statins-possible-noncardiovascular-benefits/abstract/1\" class=\"nounderline abstract_t\">Friis S, Poulsen AH, Johnsen SP, et al. Cancer risk among statin users: a population-based cohort study. Int J Cancer 2005; 114:643.</a></li><li><a href=\"https://www.uptodate.com/contents/statins-possible-noncardiovascular-benefits/abstract/2\" class=\"nounderline abstract_t\">Graaf MR, Beiderbeck AB, Egberts AC, et al. The risk of cancer in users of statins. J Clin Oncol 2004; 22:2388.</a></li><li><a href=\"https://www.uptodate.com/contents/statins-possible-noncardiovascular-benefits/abstract/3\" class=\"nounderline abstract_t\">Karp I, Behlouli H, Lelorier J, Pilote L. Statins and cancer risk. Am J Med 2008; 121:302.</a></li><li><a href=\"https://www.uptodate.com/contents/statins-possible-noncardiovascular-benefits/abstract/4\" class=\"nounderline abstract_t\">Poynter JN, Gruber SB, Higgins PD, et al. Statins and the risk of colorectal cancer. N Engl J Med 2005; 352:2184.</a></li><li><a href=\"https://www.uptodate.com/contents/statins-possible-noncardiovascular-benefits/abstract/5\" class=\"nounderline abstract_t\">Kaye JA, Jick H. Statin use and cancer risk in the General Practice Research Database. Br J Cancer 2004; 90:635.</a></li><li><a href=\"https://www.uptodate.com/contents/statins-possible-noncardiovascular-benefits/abstract/6\" class=\"nounderline abstract_t\">Khurana V, Singh T, Chalasani R, et al. Statins do not reduce colon cancer risk in humans: a case control study. Gastroenterology 2004; 126 (Suppl):A452.</a></li><li><a href=\"https://www.uptodate.com/contents/statins-possible-noncardiovascular-benefits/abstract/7\" class=\"nounderline abstract_t\">Jacobs EJ, Rodriguez C, Brady KA, et al. Cholesterol-lowering drugs and colorectal cancer incidence in a large United States cohort. J Natl Cancer Inst 2006; 98:69.</a></li><li><a href=\"https://www.uptodate.com/contents/statins-possible-noncardiovascular-benefits/abstract/8\" class=\"nounderline abstract_t\">Coogan PF, Smith J, Rosenberg L. Statin use and risk of colorectal cancer. J Natl Cancer Inst 2007; 99:32.</a></li><li><a href=\"https://www.uptodate.com/contents/statins-possible-noncardiovascular-benefits/abstract/9\" class=\"nounderline abstract_t\">Eliassen AH, Colditz GA, Rosner B, et al. Serum lipids, lipid-lowering drugs, and the risk of breast cancer. Arch Intern Med 2005; 165:2264.</a></li><li><a href=\"https://www.uptodate.com/contents/statins-possible-noncardiovascular-benefits/abstract/10\" class=\"nounderline abstract_t\">Cholesterol Treatment Trialists&rsquo; (CTT) Collaboration, Baigent C, Blackwell L, et al. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet 2010; 376:1670.</a></li><li><a href=\"https://www.uptodate.com/contents/statins-possible-noncardiovascular-benefits/abstract/11\" class=\"nounderline abstract_t\">Dale KM, Coleman CI, Henyan NN, et al. Statins and cancer risk: a meta-analysis. JAMA 2006; 295:74.</a></li><li><a href=\"https://www.uptodate.com/contents/statins-possible-noncardiovascular-benefits/abstract/12\" class=\"nounderline abstract_t\">Browning DR, Martin RM. Statins and risk of cancer: a systematic review and metaanalysis. Int J Cancer 2007; 120:833.</a></li><li><a href=\"https://www.uptodate.com/contents/statins-possible-noncardiovascular-benefits/abstract/13\" class=\"nounderline abstract_t\">Cholesterol Treatment Trialists' (CTT) Collaboration, Emberson JR, Kearney PM, et al. Lack of effect of lowering LDL cholesterol on cancer: meta-analysis of individual data from 175,000 people in 27 randomised trials of statin therapy. PLoS One 2012; 7:e29849.</a></li><li><a href=\"https://www.uptodate.com/contents/statins-possible-noncardiovascular-benefits/abstract/14\" class=\"nounderline abstract_t\">Khurana V, Bejjanki HR, Caldito G, Owens MW. Statins reduce the risk of lung cancer in humans: a large case-control study of US veterans. Chest 2007; 131:1282.</a></li><li><a href=\"https://www.uptodate.com/contents/statins-possible-noncardiovascular-benefits/abstract/15\" class=\"nounderline abstract_t\">Nielsen SF, Nordestgaard BG, Bojesen SE. Statin use and reduced cancer-related mortality. N Engl J Med 2012; 367:1792.</a></li><li><a href=\"https://www.uptodate.com/contents/statins-possible-noncardiovascular-benefits/abstract/16\" class=\"nounderline abstract_t\">Yu O, Eberg M, Benayoun S, et al. Use of statins and the risk of death in patients with prostate cancer. J Clin Oncol 2014; 32:5.</a></li><li><a href=\"https://www.uptodate.com/contents/statins-possible-noncardiovascular-benefits/abstract/17\" class=\"nounderline abstract_t\">Larsen SB, Dehlendorff C, Skriver C, et al. Postdiagnosis Statin Use and Mortality in Danish Patients With Prostate Cancer. J Clin Oncol 2017; 35:3290.</a></li><li><a href=\"https://www.uptodate.com/contents/statins-possible-noncardiovascular-benefits/abstract/18\" class=\"nounderline abstract_t\">Caporaso NE. Statins and cancer-related mortality--let's work together. N Engl J Med 2012; 367:1848.</a></li><li><a href=\"https://www.uptodate.com/contents/statins-possible-noncardiovascular-benefits/abstract/19\" class=\"nounderline abstract_t\">Tonelli M, Moy&eacute; L, Sacks FM, et al. Effect of pravastatin on loss of renal function in people with moderate chronic renal insufficiency and cardiovascular disease. J Am Soc Nephrol 2003; 14:1605.</a></li><li><a href=\"https://www.uptodate.com/contents/statins-possible-noncardiovascular-benefits/abstract/20\" class=\"nounderline abstract_t\">Vidt DG, Cressman MD, Harris S, et al. Rosuvastatin-induced arrest in progression of renal disease. Cardiology 2004; 102:52.</a></li><li><a href=\"https://www.uptodate.com/contents/statins-possible-noncardiovascular-benefits/abstract/21\" class=\"nounderline abstract_t\">Ando H, Takamura T, Ota T, et al. Cerivastatin improves survival of mice with lipopolysaccharide-induced sepsis. J Pharmacol Exp Ther 2000; 294:1043.</a></li><li><a href=\"https://www.uptodate.com/contents/statins-possible-noncardiovascular-benefits/abstract/22\" class=\"nounderline abstract_t\">Merx MW, Liehn EA, Janssens U, et al. HMG-CoA reductase inhibitor simvastatin profoundly improves survival in a murine model of sepsis. Circulation 2004; 109:2560.</a></li><li><a href=\"https://www.uptodate.com/contents/statins-possible-noncardiovascular-benefits/abstract/23\" class=\"nounderline abstract_t\">Giusti-Paiva A, Martinez MR, Felix JV, et al. Simvastatin decreases nitric oxide overproduction and reverts the impaired vascular responsiveness induced by endotoxic shock in rats. Shock 2004; 21:271.</a></li><li><a href=\"https://www.uptodate.com/contents/statins-possible-noncardiovascular-benefits/abstract/24\" class=\"nounderline abstract_t\">Terblanche M, Almog Y, Rosenson RS, et al. Statins: panacea for sepsis? Lancet Infect Dis 2006; 6:242.</a></li><li><a href=\"https://www.uptodate.com/contents/statins-possible-noncardiovascular-benefits/abstract/25\" class=\"nounderline abstract_t\">Terblanche M, Almog Y, Rosenson RS, et al. Statins and sepsis: multiple modifications at multiple levels. Lancet Infect Dis 2007; 7:358.</a></li><li><a href=\"https://www.uptodate.com/contents/statins-possible-noncardiovascular-benefits/abstract/26\" class=\"nounderline abstract_t\">Stefanec T. The effects of statins on mortality rates among bacteremic patients. Clin Infect Dis 2002; 34:1158.</a></li><li><a href=\"https://www.uptodate.com/contents/statins-possible-noncardiovascular-benefits/abstract/27\" class=\"nounderline abstract_t\">Almog Y, Shefer A, Novack V, et al. Prior statin therapy is associated with a decreased rate of severe sepsis. Circulation 2004; 110:880.</a></li><li><a href=\"https://www.uptodate.com/contents/statins-possible-noncardiovascular-benefits/abstract/28\" class=\"nounderline abstract_t\">Thomsen RW, Hundborg HH, Johnsen SP, et al. Statin use and mortality within 180 days after bacteremia: a population-based cohort study. Crit Care Med 2006; 34:1080.</a></li><li><a href=\"https://www.uptodate.com/contents/statins-possible-noncardiovascular-benefits/abstract/29\" class=\"nounderline abstract_t\">Hackam DG, Mamdani M, Li P, Redelmeier DA. Statins and sepsis in patients with cardiovascular disease: a population-based cohort analysis. Lancet 2006; 367:413.</a></li><li><a href=\"https://www.uptodate.com/contents/statins-possible-noncardiovascular-benefits/abstract/30\" class=\"nounderline abstract_t\">Gupta R, Plantinga LC, Fink NE, et al. Statin use and sepsis events [corrected] in patients with chronic kidney disease. JAMA 2007; 297:1455.</a></li><li><a href=\"https://www.uptodate.com/contents/statins-possible-noncardiovascular-benefits/abstract/31\" class=\"nounderline abstract_t\">Majumdar SR, McAlister FA, Eurich DT, et al. Statins and outcomes in patients admitted to hospital with community acquired pneumonia: population based prospective cohort study. BMJ 2006; 333:999.</a></li><li><a href=\"https://www.uptodate.com/contents/statins-possible-noncardiovascular-benefits/abstract/32\" class=\"nounderline abstract_t\">Thomsen RW, Riis A, Kornum JB, et al. Preadmission use of statins and outcomes after hospitalization with pneumonia: population-based cohort study of 29,900 patients. Arch Intern Med 2008; 168:2081.</a></li><li><a href=\"https://www.uptodate.com/contents/statins-possible-noncardiovascular-benefits/abstract/33\" class=\"nounderline abstract_t\">Chalmers JD, Singanayagam A, Murray MP, Hill AT. Prior statin use is associated with improved outcomes in community-acquired pneumonia. Am J Med 2008; 121:1002.</a></li><li><a href=\"https://www.uptodate.com/contents/statins-possible-noncardiovascular-benefits/abstract/34\" class=\"nounderline abstract_t\">Douglas I, Evans S, Smeeth L. Effect of statin treatment on short term mortality after pneumonia episode: cohort study. BMJ 2011; 342:d1642.</a></li><li><a href=\"https://www.uptodate.com/contents/statins-possible-noncardiovascular-benefits/abstract/35\" class=\"nounderline abstract_t\">Yende S, Milbrandt EB, Kellum JA, et al. Understanding the potential role of statins in pneumonia and sepsis. Crit Care Med 2011; 39:1871.</a></li><li><a href=\"https://www.uptodate.com/contents/statins-possible-noncardiovascular-benefits/abstract/36\" class=\"nounderline abstract_t\">Tleyjeh IM, Kashour T, Hakim FA, et al. Statins for the prevention and treatment of infections: a systematic review and meta-analysis. Arch Intern Med 2009; 169:1658.</a></li><li><a href=\"https://www.uptodate.com/contents/statins-possible-noncardiovascular-benefits/abstract/37\" class=\"nounderline abstract_t\">Chopra V, Rogers MA, Buist M, et al. Is statin use associated with reduced mortality after pneumonia? A systematic review and meta-analysis. Am J Med 2012; 125:1111.</a></li><li><a href=\"https://www.uptodate.com/contents/statins-possible-noncardiovascular-benefits/abstract/38\" class=\"nounderline abstract_t\">van den Hoek HL, Bos WJ, de Boer A, van de Garde EM. Statins and prevention of infections: systematic review and meta-analysis of data from large randomised placebo controlled trials. BMJ 2011; 343:d7281.</a></li><li><a href=\"https://www.uptodate.com/contents/statins-possible-noncardiovascular-benefits/abstract/39\" class=\"nounderline abstract_t\">Novack V, MacFadyen J, Malhotra A, et al. The effect of rosuvastatin on incident pneumonia: results from the JUPITER trial. CMAJ 2012; 184:E367.</a></li><li><a href=\"https://www.uptodate.com/contents/statins-possible-noncardiovascular-benefits/abstract/40\" class=\"nounderline abstract_t\">Tonolo G, Melis MG, Formato M, et al. Additive effects of Simvastatin beyond its effects on LDL cholesterol in hypertensive type 2 diabetic patients. Eur J Clin Invest 2000; 30:980.</a></li><li><a href=\"https://www.uptodate.com/contents/statins-possible-noncardiovascular-benefits/abstract/41\" class=\"nounderline abstract_t\">Sp&oacute;sito AC, Mansur AP, Coelho OR, et al. Additional reduction in blood pressure after cholesterol-lowering treatment by statins (lovastatin or pravastatin) in hypercholesterolemic patients using angiotensin-converting enzyme inhibitors (enalapril or lisinopril). Am J Cardiol 1999; 83:1497.</a></li><li><a href=\"https://www.uptodate.com/contents/statins-possible-noncardiovascular-benefits/abstract/42\" class=\"nounderline abstract_t\">Preiss D, Tikkanen MJ, Welsh P, et al. Lipid-modifying therapies and risk of pancreatitis: a meta-analysis. JAMA 2012; 308:804.</a></li><li><a href=\"https://www.uptodate.com/contents/statins-possible-noncardiovascular-benefits/abstract/43\" class=\"nounderline abstract_t\">Gokce M&#304;, G&uuml;lp&#305;nar &Ouml;, &Ouml;zt&uuml;rk E, et al. Effect of atorvastatin on erectile functions in comparison with regular tadalafil use. A prospective single-blind study. Int Urol Nephrol 2012; 44:683.</a></li><li><a href=\"https://www.uptodate.com/contents/statins-possible-noncardiovascular-benefits/abstract/44\" class=\"nounderline abstract_t\">La Vignera S, Condorelli RA, Vicari E, Calogero AE. Statins and erectile dysfunction: a critical summary of current evidence. J Androl 2012; 33:552.</a></li><li><a href=\"https://www.uptodate.com/contents/statins-possible-noncardiovascular-benefits/abstract/45\" class=\"nounderline abstract_t\">Park K, Cho SY, Kim SW. Erectile response to type 5 phosphodiesterase inhibitor could be preserved with the addition of simvastatin to conventional insulin treatment in rat model of diabetes. Int J Androl 2011; 34:e468.</a></li><li><a href=\"https://www.uptodate.com/contents/statins-possible-noncardiovascular-benefits/abstract/46\" class=\"nounderline abstract_t\">Trivedi D, Kirby M, Wellsted DM, et al. Can simvastatin improve erectile function and health-related quality of life in men aged &ge;40 years with erectile dysfunction? Results of the Erectile Dysfunction and Statins Trial [ISRCTN66772971]. BJU Int 2013; 111:324.</a></li><li><a href=\"https://www.uptodate.com/contents/statins-possible-noncardiovascular-benefits/abstract/47\" class=\"nounderline abstract_t\">El-Sisi AA, Hegazy SK, Salem KA, AbdElkawy KS. Atorvastatin improves erectile dysfunction in patients initially irresponsive to Sildenafil by the activation of endothelial nitric oxide synthase. Int J Impot Res 2013; 25:143.</a></li><li><a href=\"https://www.uptodate.com/contents/statins-possible-noncardiovascular-benefits/abstract/48\" class=\"nounderline abstract_t\">Dadkhah F, Safarinejad MR, Asgari MA, et al. Atorvastatin improves the response to sildenafil in hypercholesterolemic men with erectile dysfunction not initially responsive to sildenafil. Int J Impot Res 2010; 22:51.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 4552 Version 28.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H12\"><span>SUMMARY</span></a></li><li><a href=\"#H1\" id=\"outline-link-H1\">INTRODUCTION</a></li><li><a href=\"#H2\" id=\"outline-link-H2\">DEMENTIA</a></li><li><a href=\"#H3\" id=\"outline-link-H3\">CANCER</a></li><li><a href=\"#H4\" id=\"outline-link-H4\">RENAL FUNCTION</a></li><li><a href=\"#H5\" id=\"outline-link-H5\">SEPSIS AND INFECTIONS</a></li><li><a href=\"#H6\" id=\"outline-link-H6\">VENOUS THROMBOEMBOLISM</a></li><li><a href=\"#H338909734\" id=\"outline-link-H338909734\">MULTIPLE SCLEROSIS</a></li><li><a href=\"#H7\" id=\"outline-link-H7\">OTHER</a><ul><li><a href=\"#H8\" id=\"outline-link-H8\">Bone metabolism</a></li><li><a href=\"#H9\" id=\"outline-link-H9\">Hypertension</a></li><li><a href=\"#H10\" id=\"outline-link-H10\">Heart failure</a></li><li><a href=\"#H45574360\" id=\"outline-link-H45574360\">COPD outcomes</a></li><li><a href=\"#H11\" id=\"outline-link-H11\">Pancreatic and biliary effects</a></li><li><a href=\"#H87225680\" id=\"outline-link-H87225680\">Erectile dysfunction</a></li></ul></li><li><a href=\"#H12\" id=\"outline-link-H12\">SUMMARY</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=antihypertensive-drugs-and-lipids\" class=\"medical medical_review\">Antihypertensive drugs and lipids</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=drugs-that-affect-bone-metabolism\" class=\"medical medical_review\">Drugs that affect bone metabolism</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=epidemiology-of-and-risk-factors-for-gallstones\" class=\"medical medical_review\">Epidemiology of and risk factors for gallstones</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=investigational-and-ineffective-therapies-for-sepsis\" class=\"medical medical_review\">Investigational and ineffective therapies for sepsis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=management-of-exacerbations-of-chronic-obstructive-pulmonary-disease\" class=\"medical medical_review\">Management of exacerbations of chronic obstructive pulmonary disease</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=management-of-low-density-lipoprotein-cholesterol-ldl-c-in-secondary-prevention-of-cardiovascular-disease\" class=\"medical medical_review\">Management of low density lipoprotein cholesterol (LDL-C) in secondary prevention of cardiovascular disease</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=prevention-of-dementia\" class=\"medical medical_review\">Prevention of dementia</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=prevention-of-venous-thromboembolic-disease-in-acutely-ill-hospitalized-medical-adults\" class=\"medical medical_review\">Prevention of venous thromboembolic disease in acutely ill hospitalized medical adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=secondary-factors-and-progression-of-chronic-kidney-disease\" class=\"medical medical_review\">Secondary factors and progression of chronic kidney disease</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=statin-therapy-in-patients-with-heart-failure\" class=\"medical medical_review\">Statin therapy in patients with heart failure</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=statins-and-chronic-kidney-disease\" class=\"medical medical_review\">Statins and chronic kidney disease</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=statins-actions-side-effects-and-administration\" class=\"medical medical_review\">Statins: Actions, side effects, and administration</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=treatment-of-dementia\" class=\"medical medical_review\">Treatment of dementia</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=treatment-of-progressive-multiple-sclerosis-in-adults\" class=\"medical medical_review\">Treatment of progressive multiple sclerosis in adults</a></li></ul></div></div>","javascript":null}